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ABSTRACT: The handicaps of the maleimides, the most commonly used reagents to link thiol 
groups (of Cys) to drugs, fluorescent labels, etc., prompted us to revise and develop an alternative, 
based on the known thia-Michael addition to activated triple bonds, which could be useful under 
physiological conditions. A drug with an amino group was converted into its propynamide and, 
in aqueous media at 37 ºC and pH 7.4, Cys derivatives were added, to afford rapidly the Z 
adduct. This chemical linker (the oxopropene-1,3-diyl group) showed advantages, in terms of 
following the reaction course: no diastereomers were formed; excellent selectivity (S– vs. NH2, 
 even at pH 10.0 and 12.0), without secondary reactions; no exchange with other thiols; and no 
incorporation of deuterium at the linker when the samples were dissolved in D2O to register their NMR spectra. 
 
Conventional cancer treatments that use cytotoxic compounds cause serious side effects due to their lack of selectivity for tumor cells. 
As known, a very promising strategy to avoid or alleviate these drawbacks is to conjugate cytotoxic drugs with antibodies (targeted 
therapy).1 The preparation of antibody–drug conjugates (ADCs) requires efficient and reliable linkage protocols.2 Most ADCs currently 
on the market (4 are currently FDA-approved) and in clinical development use the Michael addition reaction of a native or genetically-
engineered Cys in the antibody to a maleimide group to form the conjugate.3 This transformation is widely used because the reaction is 
quantitative and fast under physiological conditions; however, the adducts may undergo thiol exchange in vivo causing off-site 
cytotoxicity and compromising the efficacy of the conjugate.4,5 Other Cys conjugations have been reported (Scheme 1)6, including the 
addition to electron-deficient alkynes.7 
 Our long-standing interest in the conjugate addition of several nucleophiles to activated triple bonds8 has recently led us to examine the 
possibility of going a step further: whether, under real physiological conditions, these reagents—specifically, propynamides—will or will 
not be useful to bind or link (as a linchpin or link pin) thiols and amines (Scheme 2). In other words, from our own work8 and from that of 
our colleagues Arjona and Plumet,9 we were aware that HC≡C–EWG compounds with strong EWGs such as SO2R and COOR are capable 
of reacting at rt even with very weak nucleophiles, in the presence of suitable catalysts. We did not know, however, if the reactions of Cys 
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addition products (adducts) would be stable enough in physiological media and in the presence of other thiols. The carboxamido groups 
(CONHR and CONR2), although weaker EWGs, are much more resistant to chemical hydrolysis than ester groups, and so could function as 
a suitable point of attachment for any drug "decorated" with amino groups. In this Note we report our results in this direction. 
_________________________________________________________ 
Scheme 1. Summary of Reactions for the Modification or Protection of 




Scheme 2. Reactions and Starting Materials Used as Models 
 
_________________________________________________ 
 The acylation of a primary or secondary amine with commercially available reagents such as propynoic acid (also known as 
propiolic or propargylic acid) and 3-trimethylsilylpropynoic acid (followed by desilylation), in the presence of a coupling agent (for 
example, dicyclohexylcarbodiimide, DCC, or any of its analogs) are well-known reactions.10 In the direct reaction, variable yields are 
usually reported because the product may undergo, either in situ or during the workup, the addition of the amine and/or any nucleophile 
present. With the C-silylated derivative, two steps are necessary—coupling in the presence of any dehydrating agent, followed by 
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will not comment further on the standard preparations of the starting propynamides (Scheme 2), since this Note is tightly focused on 
their reactions with thiols in aqueous media. 
 Reactions of a protected cysteine (1), cysteine itself (Cys, 2) and a cysteine-containing pseudo-tripeptide (the natural antioxidant 
glutathione, 3) with N-substituted propynamide a and N,N-disubstituted propynamide b were examined in water or in a mixture of water and a 
miscible organic solvent. "Water" means here a phosphate-buffered aqueous solution of pH 7.4. A summary is shown in Table 1. Although the 
reactions in buffered water were complete, the use of tBuOH–H2O, EtOH–H2O, or THF–H2O was also studied due to the poor solubility of a 
and b in buffered water. For the linkage of two water-soluble biomolecules, the addition of an alcohol or THF will be unnecessary. 
Table 1. Screening the Reaction Conditions for the Addition of the Thiol Group of Cysteines to 
Propynamides a and ba 
            
entry thiol alkyne solvent(s) pH T (ºC) t (min) yield (%)a   Z/Eb 
1 1 a H2O or tBuOH–H2O 6.0 rt 1,000      1a, 5  50:50 
2 1 a H2O 7.4 rt 70 1a, 93   98:2 
3 1 a H2O 7.4 37 60 1a, 94   98:2 
4 1 a EtOH–H2O, 1:1 7.4 37 50 1b, 98   93:7 
5 1 b H2O 7.4 37 50 1b, 98 >99:1d 
6 1 b tBuOH–H2O, 1:1 7.4 37 40 1b, 98 >99:1d 
7 2 a H2O 7.4 rt 70 2a, 92   98:2 
8 2 a tBuOH–H2O, 1:1 7.4 37 60 2a, 96 >99:1d 
9 2 a THF–H2O, 1:1 7.4 37 60 2a, 92   85:15 
10 2 a THF–H2O, 1:3c 7.4 37 60 2a, 94   98:2 
11 2 a tBuOH–H2O, 1:1 10.0 37 30 2a, 96  >99:1d 
12 2 a H2O 12.0 37 30 2a, 92  88:12 
13 2 b H2O 7.4 37 40 2b, 99   95:5 
14 2 b THF–H2O, 1:1 7.4 37 40 2b, 96   65:35 
15 2 b THF–H2O, 1:3c 7.4 37 40 2b, 97 >99:1d 
16 2 b tBuOH–H2O, 1:1 7.4 37 40 2b, 97 >99:1d 
17 3 a tBuOH–H2O, 1:1 7.4 37 60 3a, 93 >99:1d 
18 3 a THF–H2O, 1:3c 10.0 37 40 3a, 95   95:5 
19 3 b H2O 7.4 37 40 3b, 95   95:5 
20 3 b tBuOH–H2O, 1:1 7.4 37 40 3b, 98 >99:1d 
21 3 b THF–H2O, 1:3c 10.0 37 40 3b, 93   95:5 
  aThiols 1–3 (0.20–0.50 mmol) were dissolved in phosphate-buffered solutions (2.5 mL) under N2; in the cases of 2 and 
  3, solid K2HPO4 was added until the pH value was 7.40 (pHmeter). These solutions were then slowly added, over 10 
  min, to the propynamides (0.22–0.55 mmol) in 2.5 mL of either H2O, EtOH, tBuOH, THF or aqueous THF. Phosphate 
  buffer was not added in entry 1, but the pH was continuously measured (pHmeter, 6.0). In other cases the pH was adjusted 
  to 10.0 by addition of K2CO3 and to 12.0 with K3PO4. Stirring under N2 at rt or in a bath at 37 ± 1 ºC was maintained for 
  further 10–60 min. Isolated yields are given for 1a and 1b, before removing small amounts of isomers E (when necessary) 
  by column chromatography. Yields before recrystallization are given for zwitterions 2a,b and 3a,b (see Experimental 
  Section). bZ/E ratios were determined by 1H NMR before purification. cThe propynamide was dissolved in buffered water 
  + THF to ensure that H2O predominated in the medium from the very beginning. dThe minor isomer was not detected 
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 As shown in Table 1, the reactions of 1–3 with a and b were completed in 40–70 min even at concentrations of the reactants ≤ 0.1 
M, either at rt or 37 ºC. Excellent isolated yields of the desired adducts were obtained (by TLC chromatography and NMR the 
conversions were complete). At 0.5 M concentrations, only a few minutes were required, as expected, but we were interested in 
examining the reactions under dilute conditions for the potential application of the protocol to mAbs or to molecular scaffolds. 
 The Z diastereomer was always obtained with excellent diastereoselectivity, except for two cases: in entries 9 and 14, when a non-
hydroxylic solvent such as THF was used. However, it was sufficient to perform the addition with propynamides a and b dissolved in a 
mixture of THF and buffered water to avoid the formation of isomer E. In other words, in buffered water or a hydroxylic solvent as the 
medium throughout the reaction time, the protonation of the addition intermediate is so rapid that isomer Z largely predominates. 
The 1:1 tBuOH–buffered H2O mixture was the medium of choice with both the N-substituted and N,N-disubstituted carboxamides. 
 No catalyst or additives were necessary for the reactions in Table 1. They did not progress in water at pH < 6, but in water at pH 7.4, 
the thiol protons are sufficiently acid (pKa of Cys = 8.18, general pKa range in proteins ≈ 7.4–9.1)11 to be in equilibrium with a certain 
percentage of thiolate ion, which attacks the most electron-deficient carbon of the activated triple bond. The rapid protonation of the 
anionic adduct7a leads to a well-known trans-addition, in such a way that the substituents of the double bond turn out to be cis. This is 
an advantage of all thia-Michael additions in relation to other click reactions for thiols, since (potentially) toxic catalysts and/or water-
insoluble additives can be avoided. This is in sharp contrast to parallel conjugate additions of thiols in organic solvents, which require 
catalysis by nucleophiles and which preferentially lead to E isomers.8,9 For example, 1 and a, treated with catalytic amounts of DABCO 
in anhydrous CH3CN at rt, quantitatively gave the E isomer (data not included in Table 1, for the sake of simplicity), which showed 
olefin protons at δH 5.92 and 7.46 ppm, 3J = 14.8 Hz and olefin carbons at δC 118.1 and 141.6 ppm.  
 What matters here is that the competition between the thiol and the amino group of 2 or 3 was won by the first. It reacted with 
complete selectivity with the alkyne, even when using water at pH 10.0 (entries 11, 18, and 21): no products derived from the attack of 
the amino group were detected in any case.7a In one experiment at pH 12.0 with 2 and a (entry 12), we once again observed that only the 
thiolate ion was added to the triple bond (formation of 2a, no attack through the amino group). In summary, the thiolate ion is more 
reactive than the amino group, in conjugate additions to propynamides. The reaction of 2 with commercially available N-benzyl-
maleimide [N-(phenylmethyl)maleimide, c], at pH 10.0 and pH 12.0, also afforded only the products arising from the thiolate addition, 
but the product, 2c, underwent ring opening. 
 Isomers Z of 1a–3a and 1b–3b are readily characterized by the diagnostic NMR signals of the double bonds that are formed. In contrast, 
adducts of 1–3 with N-benzylmaleimide (c), which we prepared and isolated for the sake of comparison, were mixtures of diastereoisomers, as 
expected. This unnecessarily complicates the NMR spectra and chromatograms, as well as the future evaluation of the homogeneity of the samples 
arising from the functionalization of peptides and molecular scaffolds or platforms with several thiol groups (the characterization of which is then 
limited to the use of mass spectrometry). In Figure 1 representative spectra of 1a and 1c are compared (for expanded, high-quality spectra see 
Supporting Information). The spectra of 1a, in the left column, are very clear with relevant protons in the double bond region where overlap with 
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other signals, apart from broad NH signals of CONH, seldom occurs in protein chemistry. Also, the relevant carbon atoms of the double bond 
appear downfield and upfield, respectively, to standard aromatic and olefinic carbons. In short, there are only two proton signals in the 1H NMR 
spectrum and only two signals in the 13C NMR spectrum. In sharp contrast, in the case of succinimide 1c, see the right column, there are two sets of 
3'-CH signals while protons 4'-CH2 (in duplicate, 4 diastereotopic hydrogens, 2 diastereotopic C atoms) appear in the same 3.5–2.5 ppm and 34–37 
ppm regions as the signals of 3-CH2 (of Cys). Thus, if we had to prepare a molecular scaffold with 4 thiol groups, which by treatment with 




Figure 1. 1H and HSQC NMR Spectra of 1a (Left Column) and 1c (Right Column) 
___________________________________________________________________________________________________________ 
 
 The reactions of 1 with a and c were also followed by 1H NMR in D2O (pH 7.4, by addition of a small amount of K2HPO4). They are 
summarized in Scheme 3 (top). Incorporation of deuterium in (Z)-1a was not surprising. Incorporation of deuterium in 1c (a nearly 1:1 
diastereomeric mixture) was also evident: one of each 4'-CH2 protons of the succinimide or pyrrolidine-2,5-dione rings "disappeared" and 
the 13C NMR spectra also confirmed the monodeuteration of the CH2 groups.12 Few minutes later, a set of trideuterated isotopomers (1c-d3) 
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exchange at position 3' was also observed when 1c, prepared in tBuOH–H2O, was simply dissolved in D2O to register its NMR spectra. This 
also happened when 1c was dissolved in hot CD3OD: 86% of deuteration on C3' was noted within 1 h at 60 ºC without any additive. The 
deuteration of such a position was also very rapid with 2c and 3c, each a mixture of diastereomers as well, when dissolved in D2O, which 
was warmed for few minutes to favor the dissolution of the samples. However, in D2O with a drop of TFA no exchange was observed. In 
other words, not only are the succinimides such as 1c–3c labile in basic media, with ring opening, and sensitive to exchange reactions 
with other thiols4,5 (either by elimination–addition reactions or by direct substitutions), but there are rapid proton exchanges at the S–
CH–CO moiety, probably via its enolate-like anion at pH ≥ 7.4. 
 Carboxamides 1a, 1b, 2a, 2b, 3a, and 3b are reported here for the first time. They have been fully characterized. Their 1H and 13C 
NMR spectra and relevant 2D NMR spectra are provided as Supporting Information. 
___________________________________________________ 
     Scheme 3. Deuterated Species Observed in D2O 
 
_____________________________________________________ 
 An alternative to the preparation of the thia-Michael adducts just described is the addition–elimination reaction of thiols with β-
halopropenamides (β-haloacrylamides), a known reaction,13 but not reported in aqueous solvents or with biologically relevant thiols.14 When 1–
3 were treated with β-haloacrylamides d and e under physiological conditions, the expected adducts were obtained in excellent yields and with 
complete retention of the stereochemistry of the double bond (Scheme 4, top). Addition of 1–3 to propenamide (acrylamide) f also took place 
under the same conditions, but more slowly. In fact, the qualitative order of reactivity, as observed by 1H NMR, was: propynamide a >> (Z)-
iodopropenamide d > (E)-iodopropenamide e >> propenamide g (Scheme 4, bottom). Thus, activated triple bonds react with nucleophiles more 
rapidly than similarly activated double bonds, which is a textbook statement. Nevertheless, maleimide c (with two CO groups activating the 
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 In our hands, from qualitative competition experiments at pH 7.4 as always, in tBuOH–H2O to ensure that all the starting compounds 
remain soluble, maleimide c appeared to be more electrophilic than ethyl propynoate (HC≡C–COOEt) and morpholine amide of propynoic 
acid (b), which is slightly more reactive than a. However, maleimide c is less reactive than tosylacetylene9a and ethynyl phenyl sulfone 
("besylacetylene", HC≡C–SO2Ph).8f High reactivity is very often incompatible with the chemoselectivity that is desired, in agreement with the 
reactivity–selectivity principle, so we were not interested in examining a variety of HC≡C–EWG with very strong EWGs. 
_______________________________________________________ 




 A final issue concerns the stability of the carbonylvinylsulfide moiety, that is, of the S–linker bond, in the presence of other thiols and under 
acidic or basic conditions. Several experiments were carried out in this regard. By addition to 1a of an equivalent amount of 1 in tBuOH–H2O at 
pH 7.4 and 37 ºC, with overnight stirring, no change was observed (no formation of dithioacetal, no isomerization at all to the E isomer).16 We 
had to add 4 equiv of 1, under these conditions, to observe a 25% of Z-to-E isomerization and nothing else. Furthermore, addition to (Z)-1b, 
again in tBuOH–H2O at pH 10.0 and 37 ºC, with overnight stirring, of 1 or 4 equiv of 12-dodecanethiol did not produce any change. Also, the 
S–CH=CH–CO linkage turned out to be stable in acidic media, since the dissolution of 1a–3a and 1b–3b in water with 10% TFA, again 
overnight in a bath at 37 ºC, did not cleave the linker (only hydrolysis of the ester group of 1a and 1b was observed). Some NMR spectra of 2a 
and 3a were registered in TFA without decomposition. Moreover, in a basic medium, addition of 10% of Et3N to tBuOH–H2O solutions of 1a 
and overnight stirring, as always at 37 ºC, did not affect the linker (only the ester group was saponified, as expected). This is not the case with 
1c, the succinimide ring of which was cleaved under these conditions, in agreement with literature reports.4,5 We also observed that succinimide 
2c, once dissolved in DMSO-d6, was cleaved within 1 h by addition of K2HPO4/D2O. To summarize, in contrast to the 3-(thioalkoxy)-
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 Last but not least, as a proof of concept, we started synthesis of a more complex model from a known carboxylic acid,17 a derivative of a 
drug candidate (see Scheme 5) that was available in our lab in connection with a different project and which we prepared in accordance 
with the reported procedure.17 Although the details will be reported elsewhere, we can advance that we attached this carboxyl derivative to 
commercially available 3-azidopropylamina (3-azido-1-propanamine), which may be considered the simplest model of a spacer. After 
reduction of the azido group to amine (by catalytic hydrogenation, but other already classical routes were also successful18), conversion to 
its propynamide g (see Scheme 5) was effected by standard procedures mentioned in the introduction. We treated 1 and 2 with g in tBuOH–
H2O at pH 7.4 and 37 ºC, also at approximately 0.1 M concentrations of the reactants. The reactions were completed within 2 h, to afford 
enantiopure 1g and 2g, which were characterized by NMR and MS as usual (see Experimental Section). 
______________________________________________ 
       Scheme 5. Synthesis of 1g and 2g 
 
_____________________________________________ 
In conclusion, from a simple conjugate addition—a known thia-Michael reaction—we have developed a practical linker for the bio-
conjugation of Cys derivatives under physiological conditions, without additives, with substrates containing a propynamide group (that is, a 
moderately activated triple bond, which has advantages, as shown herein). It can be considered another click reaction. We recognize that the 
application of these new methodological results, which complement those reported in the chemistry literature, to real ADCs is still far off and that 
the stability in vivo of the linker has yet to be studied; these studies were outside the scope of the present work, but they are our next objective. 
EXPERIMENTAL SECTION 
General Methods. Unless specified otherwise, all starting materials and reagents were obtained from commercial suppliers and used without further 
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according to standard procedures. Analytical thin-layer chromatography (TLC) was performed on 0.25 mm silica gel plates (F254). Retention factors (Rf) 
are approximate. Flash column chromatography was performed on silica gel 60 (35–70 µm). Melting points or decomposition temperatures were 
obtained with a Gallenkamp apparatus. 1H NMR spectra were recorded in CDCl3 on 400 MHz spectrometers; chemical shifts are given in ppm with the 
solvent resonance as the internal standard (residual CHCl3 in CDCl3, δ 7.26 ppm; residual CD3SOCHD2 in DMSO-d6, δ 2.50 ppm; DOH in D2O, δ 4.79 
ppm). Data are reported as usual: chemical shift in δ, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet, br s = broad singlet, m 
= multiplet), coupling constants in Hz, and integration. For cysteine derivatives 2a–c and 3a–c the solvent was D2O, but one or two drops of TFA had to 
be added to help solubilize 2a–c and to avoid deuteration at C3' in the case of 3c, with a glass capillary filled with CHCl3 inside, that is, with CHCl3 as 
external reference. 13C NMR spectra were recorded in CDCl3, DMSO-d6, or D2O at 100.6 MHz with proton decoupling. Chemical shifts are reported in 
ppm (CDCl3, δ 77.0 ppm; DMSO-d6, δ 39.5 ppm). For 2a–c and 3a–c the solvent was D2O, plus one or two drops of TFA in the cases of 2a–c and 3c, 
with an internal capillary filled with CDCl3 [TFA in CDCl3, δ 116.5 (q, J = 290.4 Hz), 164.4 (q, J = 36.6 Hz], as external reference. Where necessary, 
2D NMR experiments (HSQC and NOESY, mainly) were carried out to assist in structure elucidation and signal assignments. FTIR spectra were 
registered with an ATR accessory; only the more relevant frequencies (cm–1) are reported. HRMS were obtained by using ESI–TOF techniques. 
General Procedure for the Addition of Thiols 1–3 to Propynamides (Propiolamides) a and b in Aqueous Media. Thiols 1–3 (in 
general, 0.20–0.50 mmol) were dissolved in phosphate-buffered solutions (2.5 mL) under N2; in the cases of 2 and 3, solid K2HPO4 was added 
until the pH value was 7.40 (pHmeter). These solutions were slowly added, over 10 min, to the propynamides (0.22–0.55 mmol) in 2.5 mL of 
H2O, tBuOH, EtOH, THF, or THF–buffered water, either at rt or 37 ºC. The reactions were stirred until TLC analysis indicated complete 
consumption of the substrate (usually for further 10–60 min, see Table 1). The conversion yields were 100% in all cases, at pH ≥ 7.4. 
The reaction mixtures from 1 were diluted with H2O and extracted three times with CH2Cl2. The organic layers were collected, dried over 
anhydrous MgSO4, filtered, concentrated under vacuum, and analyzed by NMR (last column in Table 1). The residues were usually purified by 
column chromatography on silica gel (to remove small amounts of the E isomers) and the solids were then stored in vacuum desiccators over P4O10 
until constant weight (isolated yields, Table 1). The reaction mixtures from 2 were concentrated under vacuum (to remove tBuOH) and the 
precipitates that appeared were filtered, rinsed with water, dried under vacuum over P4O10, weighted, and analyzed by TLC and NMR (yields and 
percentages given in Table 1). The crude products from most experiments were chromatographically and spectroscopically pure (only the Z isomers 
of 2a and 2b); no recrystallization was needed. The reaction mixtures from 3 were acidified to pH 3.5 with NaH2PO4 (plus a drop of H3PO4) and a 
similar volume of EtOH was added and separated (three times), the moist EtOH solutions were evaporated to dryness, the residues were treated 
with 4:1 iPrOH–H2O, the solutions were filtered through Celite® (to remove remaining amounts of the insoluble phosphates) and rinsed with the 
same mixture (iPrOH–H2O), evaporated to dryness, stored in the desiccator, weighted (yield in Table 1), and analyzed by NMR (last column in 
Table 1). In two experiments (in which a mixture of stereoisomers was formed), the crude products were recrystallized from iPrOH–H2O (80–85% 
recovery) to remove the minor E isomers. 
We proceeded similarly with the other commercially available Michael acceptors: N-(phenylmethyl)maleimide, or N-benzylmaleimide, c; 
N-benzyl-3-iodopropenamides d and e; and N-benzylpropenamide f. 
Methyl N-acetyl-S-[(Z)-3-phenylmethylamino)-3-oxo-1-propen-1-yl]-L-cysteinate, (Z)-1a. Yield: 94% (91 mg). White solid; mp 123–125 °C; Rf = 0.30 
(CH2Cl2/MeOH, 98:2). 1H NMR (CDCl3) 2.01 (s, 3H), 3.24 (d, J = 4.5, 2H), 3.76 (s, 3H), 4.47 (d, J = 5.8, 2H), 4.85 (m, 1H), 5.78 (d, J = 9.9, 1H), 5.89 (br 
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s, 1H), 6.43 (br s, 1H), 6.76 (d, J = 9.9, 1H), 7.29 (m, 5H). 13C NMR (CDCl3) 23.2, 38.5, 43.6, 53.0, 53.0, 116.0, 127.7, 128.1, 128.8, 138.3, 145.2, 166.0, 
170.1, 170.6. FTIR 3303, 3271, 3069, 2917, 1738, 1660, 1632. HRMS (ESI+) m/z calcd for C16H21N2O4S+ [M + H]+ 337.1217, found 337.1221. 
Methyl N-acetyl-S-[(Z)-3-N-morpholino-3-oxo-1-propen-1-yl]-L-cysteinate, (Z)-1b. Yield: 98% (89 mg). White solid; mp 177–178 ºC; Rf = 0.28 
(CH2Cl2/MeOH, 98:2). 1H NMR (CDCl3) 2.03 (s, 3H), 3.25 (d, J = 4.5, 2H), 3.49 (br s, 2H), 3.68 (br s, 6H), 3.77 (s, 3H), 4.88 (m, 1H), 6.16 (d, J = 9.9, 
1H), 6.36 (br s, 1H), 6.90 (d, J = 9.9, 1H); 13C NMR (CDCl3, 100.6 MHz) δ 23.2, 38.5, 41.9, 46.1, 52.7, 53.0, 66.8, 67.0, 111.8, 147.6, 165.5, 170.0, 
170.6. FTIR 3278, 3069, 2914, 2850, 1721, 1639, 1625, 1614. HRMS (ESI+) m/z calcd for C13H21N2O5S+ [M + H]+ 317.1166, found 317.1171. 
S-[(Z)-3-Phenylmethylamino-3-oxo-1-propen-1-yl]-L-cysteine, (Z)-2a. Yield: 96% (56 mg). White solid; dec. 215–217 ºC; Rf = 0.71 (CH2Cl2/-
MeOH/TFA, 80:15:5). 1H NMR (D2O + TFA, ref. to CHCl3) 3.41 (m, 3H), 4.40 (s, 2H), 6.09 (d, J = 10.0, 1H), 7.01 (d, J = 10.0, 1H), 7.35 (m, 5H). 13C 
NMR (D2O + TFA, ref. to CDCl3) 35.5, 43.0, 53.0, 117.4, 127.5, 129.0, 129.4, 138.3, 143.6, 170.0, 170.4. HRMS (ESI–) m/z calcd for C13H15N2O3S– [M 
– H]– 279.0809, found 279.0815.  
S-[(Z)-3-Morpholino-3-oxo-1-propen-1-yl]-L-cysteine, (Z)-2b. Yield: 97% (65 mg). White solid, dec. 198–200 ºC; Rf = 0.62 (CH2Cl2/MeOH/-
TFA, 80:15:5). 1H NMR (D2O + TFA, ref. to CHCl3) 3.55 (m, 3H), 3.83 (m, 2H), 3.97 (m, 6H), 6.66 (d, J = 10.1, 1H), 7.37 (d, J = 10.1, 1H). 13C 
NMR (D2O + TFA, ref. to CDCl3) 32.6, 36.1, 42.3, 54.3, 63.8, 66.6, 113.9, 146.0, 167.1, 172.1. HRMS (ESI–) m/z calcd for C10H15N2O4S– [M – H]– 
259.0758, found 259.0766. 
S-[(Z)-3-Phenylmethylamino-3-oxo-1-propen-1-yl]glutathione, (Z)-3a. Yield (entry 18): 93% (152 mg). White solid; dec. 236–237 ºC; Rf = 0.55 
(CH2Cl2/MeOH/TFA, 80:15:5). 1H NMR (D2O) 2.13 (m, 2H), 2.50 (t, J = 7.1, 2H), 3.08 (dd, J = 13.8, 9.8, 1H), 3.29 (d, J = 13.9, 1H), 3.75 (m, 3H), 
4.40 (s, 2H), 4.66 (m, 1H), 6.03 (d, J = 10.0, 1H), 7.03 (d, J = 10.0, 1H), 7.40 (m, 5H). 13C NMR (D2O , ref. to CDCl3) 26.4, 31.7, 37.1, 43.0, 43.6, 
54.0, 54.3, 116.3, 127.5, 127.6, 129.0, 138.5, 145.2, 168.6, 171.6, 174.1, 175.0, 176.4. HRMS (ESI+) m/z calcd for C20H27N4O7S+ [M + H]+ 
467.1595, found 467.1596; HRMS (ESI–) m/z calcd for C20H25N4O7S– [M – H]– 465.1449, found 465.1463. 
S-[(Z)-3-N-Morpholino-3-oxo-1-propen-1-yl]glutathione, (Z)-3b. Yield: 95% (146 mg). White solid; dec. 220–222 ºC; Rf = 0.55 (CH2Cl2/-
MeOH/TFA, 80:15:5). 1H NMR (D2O) 2.13 (m, 2H), 2.49 (m, 2H), 3.07 (dd, J = 14.4, 8.8, 1H), 3.28 (dd, J = 14.3, 5.0, 1H), 3.59 (m, 4H), 3.71 (m, 
7H), 4.63 (dd, J = 8.8, 5.0, 1H), 6.36 (d, J = 10.1, 1H), 7.13 (d, J = 10.2, 1H). 13C NMR (D2O, ref. to CDCl3) 26.3, 31.5, 36.8, 42.0, 43.5, 46.1, 53.8, 
54.1, 66.4, 112.9, 147.0, 167.0, 171.4, 174.0, 174.8, 176.2. HRMS (ESI+) m/z calcd for C17H27N4O8S+ [M + H]+ 447.1544, found 447.1545. HRMS 
(ESI–) m/z calcd for C17H25N4O8S– [M – H]– 445.1399, found 445.1413. 
Methyl N-acetyl-S-[(3RS)-1-phenylmethyl-2,5-dioxopyrrolidin-3-yl]-L-cysteinate, 1c. Yield: 98% (61 mg); ca. 1:1 diastereomeric mixture. 
Yellowish oil; Rf = 0.34 (hexanes/EtOAc, 20:80). 1H NMR (CDCl3) 2.02 (s, 3H), 2.04 (s, 3H), 2.46 (dd, J = 18.8, 3.9, 1H), 2.50 (dd, J = 18.8, 4.1, 
1H), 2.99 (dd, J = 14.0, 7.5, 1H), 3.14 (m, 3H), 3.45 (dd, J = 14.4, 5.2, 1H), 3.49 (dd, J = 14.0, 4.4, 1H), 3.75 (dd, J = 9.2, 4.1, 1H), 3.76 (s, 6H), 3.91 
(dd, J = 9.2, 3.9, 1H), 4.66 (m, 4H), 4.89 (m, 2H), 6.43 (br s, 1H), 6.90 (br s, 1H), 7.32 (m, 10H). 13C NMR (CDCl3) 23.2, 23.2, 34.3, 35.0, 35.8, 36.5, 
38.9, 40.4, 42.8, 42.9, 51.4, 52.4, 52.9, 53.0, 128.2, 128.3, 128.7, 128.8, 128.9, 128.9, 135.3, 135.4, 170.2, 170.3, 171.0, 171.2, 173.8, 174.1, 176.6, 
176.8. FTIR 3303, 2960, 1741, 1697, 1670, 1626. HRMS (ESI+) m/z calcd for C17H21N2O5S+ [M + H]+ 365.1166, found 365.1171. 
S-[(3RS)-1-Phenylmethyl-2,5-dioxopyrrolidin-3-yl]-L-cysteine, 2c. Yield: 94% (80 mg); nearly 1:1 diastereomeric mixture. White solid, Rf = 
0.63 (CH2Cl2/MeOH/TFA, 80:15:5), 1H NMR (D2O + TFA, ref. to CHCl3) 2.69 (br d, J = 18.8, 1H), 2.70 (br d, J = 18.8, 1H), 3.17 (dd, J = 15.0, 8.1, 
1H), 3.31 (m, 3H), 3.43 (dd, J = 15.2, 4.4, 1H), 3.49 (dd, J = 15.0, 4.4, 1H), 4.05 (dd, J = 9.8, 4.2, 1H), 4.08 (dd, J = 9.8, 4.0, 1H), 4.27 (dd, J = 8.1, 
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4.5, 1H), 4.41 (dd, J = 7.6, 4.5, 1H), 4.66 (m, 4H), 7.32 (m, 10H). 13C NMR (D2O + TFA, ref. to CDCl3) 31.0, 32.3, 35.6, 36.0, 40.0, 41.3, 42.7, 42.8, 
52.3, 53.0, 128.0, 128.0, 128.4, 129.1, 129.1, 135.2, 162.5, 162.9, 170.0, 170.1, 177.6, 178.9, 179.5. HRMS (ESI–) m/z calcd for C14H15N2O4S– [M – 
H]– 307.0758, found 307.0763. 
S-[(3RS)-1-Phenylmethyl-2,5-dioxopyrrolidin-3-yl]glutathione, 3c.19 Yield: 92% (161 mg); almost 1:1 diastereomeric mixture. White solid; Rf = 
0.54 (CH2Cl2/MeOH/TFA, 80:15:5). 1H NMR (D2O + TFA, ref. to CHCl3) 2.20 (m, 4H), 2.54 (m, 4H), 2.63 (dd, J = 9.9, 3.8, 1H), 2.68 (dd, J = 
9.9, 3.9, 1H), 2.94 (dd, J = 14.0, 8.6, 1H), 3.10 (dd, J = 14.0, 7.8, 1H), 3.11 (dd, J = 14.0, 5.6, 1H), 3.27 (dd, J = 19.0, 6.6, 1H), 3.28 (dd, J = 
19.0, 6.5, 1H), 3.95 (s, 2H), 3.97 (s, 2H), 4.01 (dd, J = 9.0, 3.9, 1H), 4.03 (dd, J = 8.9, 3.7, 1H), 4.06 (dd, J = 5.0, 1.7, 1H), 4.07 (dd, J = 6.5, 
3.3, 1H), 4.59 (d, J = 5.6, 1H), 4.61 (d, J = 5.3, 1H), 4.63 (s, 4H), 7.30 (m, 10H). 13C NMR (D2O + TFA, ref. to CDCl3) 25.4, 25.4, 30.9, 32.5, 
32.7, 35.8, 36.0, 39.9, 40.6, 41.1, 42.4, 52.2, 52.6, 53.1, 127.7, 128.1, 128.9, 135.1, 171.4, 172.2, 172.3, 172.8, 172.8, 174.2, 174.2, 177.8, 
177.8, 179.0, 179.1. 
Methyl N-acetyl-S-[(E)-3-phenylmethylamino)-3-oxo-1-propen-1-yl]-L-cysteinate, 1e [(E)-1a]. Yield: 95% (70 mg). White solid; mp 105-107 °C; Rf = 
0.30  (CH2Cl2/MeOH, 98:2). 1H NMR (CDCl3) 2.00 (s, 3H), 3.23 (dd, J = 14.1, 4.8, 1H), 3.32 (dd, J = 14.1, 5.0, 1H), 3.77 (s, 3H), 4.46 (d, J = 5.6, 
2H), 4.88 (dt, J = 7.3, 4.9, 1H), 5.92 (d, J = 14.9, 1H), 6.15 (br s, 1H), 6.57 (br d, J = 7.3, 1H), 7.27 (m, 5H), 7.50 (d, J = 14.9, 1H). 13C NMR 
(CDCl3) 23.0, 34.6, 43.7, 52.0, 53.0, 117.7, 127.5, 127.8, 128.7, 138.1, 141.8, 164.1, 170.2, 170.4. HRMS (ESI+) m/z calcd for C16H21N2O4S+ [M + H]+ 
337.1215, found 337.1221. 
Methyl N-acetyl-S-(3-phenylmethylamino-3-oxopropyl)-L-cysteinate, 1f. Yield: 91% (99 mg). Oil; Rf = 0.66 (CH2Cl2/MeOH, 99:1). 1H NMR 
(CDCl3) 1.99 (s, 3H), 2.48 (m, 2H), 2.86 (t, J = 7.0, 2H), 2.96 (d, J = 5.1, 2H), 3.73 (s, 3H), 4.43 (d, J = 5.7, 2H), 4.80 (m, 1H), 6.35 (br s, 1H), 6.72 
(br s, 1H), 7.28 (m, 5H). 13C NMR (CDCl3) 23.0, 28.6, 34.5, 36.5, 43.7, 52.3, 52.7, 127.5, 127.8, 128.7, 138.1, 170.3, 170.8, 171.2. FTIR 3275, 3033, 
1744, 1639. HRMS (ESI+) m/z calcd for C16H23N2O4S+ [M + H]+ 339.1373, found 339.1379. 
Propynamide g. Yield: 43% (330 mg). Colorless oil; Rf = 0.47 (CH2Cl2/MeOH, 95:5). Mixture of rotamers (piperazine ring): 1H NMR 
(CDCl3) 1.25 (br s, 3H), 1.75 (m, 2H), 2.83 (s, 1H), 3.39 (s, 2H), 3.49 (s, 2H), 4.80–3.11 (m, 7H), 6.97 (br s, 1H), 7.28 (m, 1H), 7.39 (m, 5H), 
7.63 (d, J = 7.4, 1H), 7.69 (br s, 1H), 8.01 (s, 1H), 8.42 (br s, 1H), 11.42 (br s, 1H). 13C NMR (CDCl3) 15.3, 29.5, 36.0, 37.0, 40.1, 45.0, 50.1, 
74.1, 77.4, 114.3, 116.9, 121.8, 122.9, 126.1, 127.0, 127.1, 128.8, 130.2, 135.1, 135.2, 136.4, 153.3, 166.2, 167.5, 171.5, 185.6. HRMS (ESI+) 
m/z calcd for C29H30N5O5+ [M + H]+ 528.2241, found 528.2242. 
Adduct of methyl N-acetyl-L-cysteinate and propanamide g (1g). Yield: 98% (80 mg). Yellowish oil; Rf = 0.19 (CH2Cl2/MeOH, 95:5). 
Mixture of rotamers: 1H NMR (CDCl3) 1.28 (br s, 3H), 1.73 (m, 2H), 2.04 (s, 3H), 2.98–3.47 (m, 12H), 3.77 (s, 4H), 4.84 (br s, 1H), 5.79 (d, J 
= 9.9, 1H), 6.48 (br s, 1H), 6.72 (d, J = 9.7, 1H), 7.29 (m, 1H), 7.39 (m, 5H), 7.64 (d, J = 7.3, 1H), 7.73 (d, J = 6.9, 1H), 7.92 (br s, 1H), 8.02 
(m, 1H), 8.42 (br s, 1H), 11.33 (s, 1H). 13C NMR (CDCl3) 15.2, 16.4, 23.3, 29.4, 29.8, 36.3, 36.4, 36.7, 38.4, 45.0, 52.7, 52.9, 114.2, 116.4, 
117.4, 122.2, 122.9, 125.9, 126.7, 127.1, 128.8, 130.2, 135.1, 136.2, 136.6, 144.7, 167.2, 167.4, 167.5, 170.4, 170.5, 170.8, 185.6. HRMS 
(ESI+) m/z calcd for C35H41N6O8S+ [M + H]+ 705.2701, found 705.2699. 
Adduct of L-cysteine and propanamide g (2g). Yield: 97% (103 mg). Yellowish oil; Rf = 0.33 (CH2Cl2/MeOH/TFA, 80:15:5). Mixture of 
rotamers: 1H NMR (DMSO-d6) 1.21 (br s, 3H), 1.72 (quin, J = 6.9, 2H), 2.71─4.60 (m, 13H), 4.22 (s, 1H), 5.95 (d, J = 9.8, 1H), 6.90 (d, J = 
10.0, 1H), 7.40 (m, 6H), 7.82 (d, J = 7.6, 1H), 8.05 (d, J = 3.3, 1H), 8.29 (br s, 1H), 8.75 (t, J = 5.6, 1H), 12.20 (d, J = 12.9, 1H). 13C NMR 
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(DMSO-d6) 14.9, 16.0, 28.8, 29.3, 32.2, 36.8, 36.9, 37.0, 37.4, 44.3, 51.4, 112.7, 117.9, 118.5, 122.3, 122.4, 124.4, 126.3, 127.1, 128.6, 129.8, 
135.2, 135.6, 138.0, 142.3, 165.8, 165.9, 166.1, 169.4, 186.0. HRMS (ESI–) m/z calcd for C32H35N6O7S– [M – H]– 647.2293, found 647.2296. 
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